Mark Gurney

5PUBLICATIONS
11CO-AUTHORS
Medical infection agents (incl. prions)Medical genetics (excl. cancer genetics)Cheminformatics and quantitative structure-activity relationshipsClinical pharmacology and therapeuticsMedia industry studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2025
Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data.

Sreevani Katabathula, Mark Gurney, George Perry

|Apr 30, 2021
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial.

Elizabeth M Berry-Kravis, Mark D Harnett, Scott A Reines

|Aug 23, 2018
Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice.

Chong Zhang, Ying Xu, Anirudh Chowdhary

Pageof 1